Medical/Pharmaceuticals News & Press Release Distribution

Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology

June 21, 2023, at The Yale Club, New York City The Company will showcase its urologic pipeline, development of novel therapeutics, imaging agents and technologies that aim to harness the power of targeted radiation at every step of the patient journey MELBOURNE, Australia and INDIANAPOLIS, May 2...

2023-05-25 19:00 2024

Partnership between Thermo Fisher Scientific and BRIN to Strengthen Research Infrastructure and Capabilities in Indonesia

Collaboration to enhance BRIN's scientific and innovation infrastructure and talent SINGAPORE, May 25, 2023 /PRNewswire/ -- Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency ofIndonesia (BRIN, Bad...

2023-05-25 18:04 2904

Partnership between Thermo Fisher Scientific and BRIN to Strengthen Research Infrastructure and Capabilities in Indonesia

Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution

XI'AN, China, May 25, 2023 /PRNewswire/ -- Tianlong , an innovative high-tech company specializing in molecular diagnostic products in China, has partnered with public hospitals in northern Thailand to build up detection measures for hepatitis C (HCV) and hepatitis B (HB...

2023-05-25 16:42 3089

AffaMed Therapeutics Announces Partner Allgenesis Reports Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema

* AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of 0.5 mg and 1 mg in DME patients. * AG-73305 showed median improvements in Best Corrected Visual Accuity (BCVA) of 8.5 ETDRS letters with median Central Subfield Thickness...

2023-05-25 15:52 2712

Mindray Introduces Its Smart Hospital Solutions at Hospitalar 2023

SAO PAULO, Brazil, May 25, 2023 /PRNewswire/ -- Mindray, a leading global provider of medical devices and solutions, is attending one of the largest medical equipment exhibitions inSouth America, Hospitalar 2023, from May 23rd to 26th in Sao Paulo, Brazil. The company is demonstrating its latest ...

2023-05-25 15:27 2197

111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow

SHANGHAI, May 25, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that it will report its unaudited financial results ...

2023-05-25 14:05 1985

CGCT2023 The 3rd China Gene and Cell Therapy Innovation Forum will open on 9th-10th. June in Suzhou, China

SHANGHAI, May 25, 2023 /PRNewswire/ -- "If the 20th century was the era of drug therapy, then the 21st century is the era of cell therapy,"George Daley said, a biologist from theUSA. Cell and gene therapies (CGT), represented by CAR-T, have shown tremendous potential in many diseases, especially ...

2023-05-25 12:14 3279

CGCT2023 The 3rd China Gene and Cell Therapy Innovation Forum will open on 9th-10th. June in Suzhou, China

TYK2/JAK1 Inhibitor AC-201 of Accropeutics Bioscience gained Human Research Ethics Committees (HREC) permission for Phase I

SUZHOU, China, May 24, 2023 /PRNewswire/ -- Accropeutics Bioscience announced that its oral small molecule TYK2/JAK1 inhibitor AC-201 has been approved by the Australian Human Research Ethics Committee (HREC) to launch a clinical phase I trial inAustralia. The trial will be a randomized, double-b...

2023-05-25 09:51 2044

Hope for knee osteoarthritis sufferers with advent of global clinical trial.

Paradigm Biopharma launches clinical trial website to support development program for knee osteoarthritis therapy. MELBOURNE, Australia, May 25, 2023 /PRNewswire/ -- With the launch of a new website dedicated to their global clinical trials (https://hope4OA.com ), Paradigm ...

2023-05-25 09:10 2683

Catalent Adds New Cryogenic Capabilities at Shiga, Japan, Facility to Support Clinical Supply Demand for Cell and Gene Therapy Development

SOMERSET, N.J., May 25, 2023 /PRNewswire/ -- Catalent (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has expanded the services and capabilities at its facility in Shiga,Japan, to include the storage, kitting, and...

2023-05-25 08:00 5431

Catalent Adds New Cryogenic Capabilities at Shiga, Japan, Facility to Support Clinical Supply Demand for Cell and Gene Therapy Development

Lynk Pharmaceuticals Announces First Cohort of Psoriatic Patients Dosed with LNK01004 in Phase Ib Clinical Study

HANGZHOU, China, May 25, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first cohort of psoriatic patients in a Phase Ib clinical trial of its innovative drug LNK01004. ...

2023-05-25 08:00 4715

RingConn Official Website Has Been Launched on 5.18

WILMINGTON, Del., May 25, 2023 /PRNewswire/ -- RingConn, the innovative wellness brand, is excited to announce the launch of its official website, which was successfully launched onMay 18th. This milestone signifies RingConn's commitment to providing customers with cutting-edge wellness solutions...

2023-05-25 01:00 3596

RingConn Official Website Has Been Launched on 5.18

Clarity's theranostic prostate cancer trial advances to cohort 2

Highlights * Cohort 1 of the SECuRE trial has been completed in 6 participants with metastatic castrate-resistant prostate cancer (mCRPC) who received therapy with 67Cu SAR-bisPSMA at the lowest dose level of 4GBq. * No dose limiting toxicities (DLTs) have been reported in cohort 1. * The Sa...

2023-05-24 21:03 2739

Clarity's theranostic prostate cancer trial advances to cohort 2

Avixgen accelerates the progress on new drug pipeline development

- Pipeline development updates on age related macular degeneration, dry eye disease and atopic dermatitis SEOUL, South Korea, May 24, 2023 /PRNewswire/ -- DxVx has released development updates on the pipelines of its recently acquired company, Avixgen. DxVx acquired about 63% stake of Avixgen, w...

2023-05-24 21:00 2975

BioRay Filed IND Application for BRY812, a Novel Antibody Drug Conjugate Targeting LIV-1

SHANGHAI, May 24, 2023 /PRNewswire/ -- BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the Investigational New Drug (IND) application for the clinical trial of its proprietary BRY812,a novel antibody-drug conjugate (ADC) targeting human LIV-1 for the treatment o...

2023-05-24 16:14 1994

HKBN x Mannings Pioneer FREE Pharmacist Consultations for Talents

PharmaCare Pilot Programme allows HKBN Talents to enjoy HK's leading flexible benefit package HONG KONG, May 24, 2023 /PRNewswire/ -- As flu season and COVID-19 continues, long queues are common at doctor's clinics. As a Talent-obsessed company,HKBN Group ("HKBN"), and Hong Kong's largest health...

2023-05-24 14:56 2479

Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey

The survey reveals 84% of Asia Pacific Consumers recognize the importance of a support group in helping them achieve health and wellness goals HONG KONG, May 24, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released the findings of its Asia Pacific H...

2023-05-24 12:31 3126

Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey

Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema

* AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of 0.5 mg and 1 mg in DME patients. * AG-73305 showed median improvements in Best Corrected Visual Accuity (BCVA) of 8.5 ETDRS letters with median Central Subfield Thickness...

2023-05-24 10:24 1904

Chula Researchers Discover "Highly Effective Antibodies against COVID-19," Leading to "COVITRAP Nasal Spray" to Curb Infection at the Start

BANGKOK, May 24, 2023 /PRNewswire/ -- A research team at the Center of Excellence in Systems Biology, Faculty of Medicine,Chulalongkorn University, has identified "highly effective antibodies against COVID-19" from the human body. These antibodies have been developed into an innovation called "C...

2023-05-24 10:00 3065

Infinitus Meets 520 Social Responsibility Day Goal for 5 Years, Promoting Healthy Living

GUANGZHOU, China, May 24, 2023 /PRNewswire/ -- On May 20, Infinitus hosted the 520 Infinitus Social Responsibility Day for the 5th consecutive year at Infinitus Plaza inGuangzhou, centered around this year's theme, "You and I Together for a Healthy Lifestyle". The event, broadcasted live online, ...

2023-05-24 08:00 2868